GHK-Cu (Copper Peptide/Copper Tripeptide) is a naturally occurring copper complex utilized in skincare and regenerative medicine as a potent anti-aging and anti-inflammatory agent. It effectively stimulates the production of collagen and elastin, repairs the skin barrier, promotes hair root growth, and reduces wrinkles. Commonly incorporated into anti-aging serums, creams, and hair growth products, it is […]

Retatrutide is a triple agonist peptide targeting the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R); it has demonstrated superior clinical efficacy compared to semaglutide in the treatment of obesity, obesity-related Type 2 diabetes, cardiovascular diseases, and various endocrine and metabolic disorders.

In June 2021, Semaglutide was launched as a weight-loss medication. Thanks to its exceptional weight-loss efficacy, favorable safety profile, and the influence of celebrities such as Elon Musk, Semaglutide took the world by storm—reaching a point where it became incredibly difficult to obtain.